Regulation 95B of the Principal Regulations is rescinded and the following regulation is substituted:

95B.     Prescribed monitored medicines

(1)  For the purposes of paragraph (b) of the definition of monitored medicines in section 3(1) of the Act, the following are prescribed to be monitored medicines:

(a) codeine (S4);

(b) dextropropoxyphene;

(c) gabapentin;

(d) olanzapine;

(e) pregabalin;

(f) quetiapine;

(g) tramadol;

(h) zolpidem;

(i) zopiclone.

(2)  For the purposes of paragraph (c) of the definition of monitored medicines in section 3(1) of the Act, substances that are in the class of substances known as benzodiazepines are prescribed to be monitored medicines.

Displayed and numbered in accordance with the Rules Publication Act 1953 .

Notified in the Gazette on 29 June 2022

These regulations are administered in the Department of Health.

EXPLANATORY NOTE

(This note is not part of the regulation)

These regulations amend the Poisons Regulations 2018 by specifying certain substances, and certain classes of substances, to be monitored medicines for the purposes of the Poisons Act 1971 .